Gururajgovind Lifesciences Yelahanka Llp Profile
Key Indicators
- Obligation of Contribution ₹ 1.00 M
as on 23-01-2024
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 6.54 Cr
as on 23-01-2024
- Revenue 9.31%
(FY 2021)
- Profit 59.19%
(FY 2021)
- Ebitda 1.75%
(FY 2021)
- Total Assets -9.64%
(FY 2021)
About Gururajgovind Lifesciences Yelahanka Llp
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2022 (FY 2021-2022). It's Total Obligation of Contribution is Rs 1.00 M as per MCA.
- CIN/LLPIN/FCRN
AAL-6463
- Incorporation Date
08 Jan 2018
- Date of Accounts and Solvency Statement
31 Mar 2022
- ROC Code
Roc-Bangalore
- Company Classification
Limited Liability Partnership
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gururajgovind Lifesciences Yelahanka Llp?
Designated Partners(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dasanna Umashankar  | Designated Partner | 08-Jan-2018 | Current |
| Arathy Govindan | Designated Partner | 08-Jan-2018 | Current |
| Gururaj Rao | Designated Partner | 08-Jan-2018 | Current |
Financial of Gururajgovind Lifesciences Yelahanka Llp.
Gururajgovind Lifesciences Yelahanka Llp, for the financial year ended 2021, experienced modest growth in revenue, with a 9.31% increase. The company also saw a substantial improvement in profitability, with a 59.19% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gururajgovind Lifesciences Yelahanka Llp?
Unlock access to Gururajgovind Lifesciences Yelahanka Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Bhima Diagnostics Private LimitedActive 1 year 4 monthsArathy Govindan and Gururaj Rao are mutual person
- Bmom Fertility And Research Center LlpActive 10 years 4 months
Dasanna Umashankar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 20 Dec 2018 | ₹1.41 Cr | Open |
De Lage Landen Financial Services India Private Limited Creation Date: 01 Apr 2018 | ₹5.13 Cr | Open |
How Many Employees Work at Gururajgovind Lifesciences Yelahanka Llp?
Gururajgovind Lifesciences Yelahanka Llp has a workforce of 43 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gururajgovind Lifesciences Yelahanka Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gururajgovind Lifesciences Yelahanka Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
